Mostrar el registro sencillo del ítem
dc.contributor.author
Ding, Derong
dc.contributor.author
Boudreau, Marc A.
dc.contributor.author
Leemans, Erika J.
dc.contributor.author
Spink, Edward
dc.contributor.author
Yamaguchi, Takao
dc.contributor.author
Testero, Sebastian Andres
dc.contributor.author
O'Daniel, Peter I.
dc.contributor.author
Lastochkin, Elena
dc.contributor.author
Chang, Mayland
dc.contributor.author
Mobashery, Shahriar
dc.date.available
2016-06-02T18:29:51Z
dc.date.issued
2015-06
dc.identifier.citation
Ding, Derong; Boudreau, Marc A.; Leemans, Erika J.; Spink, Edward; Yamaguchi, Takao; et al.; Exploration of the Structure-Activity Relationship of 1,2,4-Oxadiazole Antibiotics; Elsevier; Bioorganic & Medicinal Chemistry Letters; 25; 21; 6-2015; 4854-4857
dc.identifier.issn
0960-894X
dc.identifier.uri
http://hdl.handle.net/11336/6004
dc.description.abstract
We have recently disclosed the discovery of the class of 1,2,4-oxadiazole antibiotics, which emerged from in silico docking and scoring efforts. This class of antibacterials exhibits Gram-positive activity, particularly against Staphylococcus aureus. We define the structure–activity relationship (SAR) of this class of antibiotics with the synthesis and evaluation of a series of 59 derivatives with variations in the C ring or C and D rings. A total of 17 compounds showed activity against S. aureus. Four derivatives were evaluated against a panel of 16 Gram-positive strains, inclusive of several methicillin-resistant S. aureus strains. These compounds are broadly active against Gram-positive bacteria.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Elsevier
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.subject
1,2,4-Oxadiazoles
dc.subject
Structureactivity Relationship
dc.subject
Antibiotics
dc.subject.classification
Química Orgánica
dc.subject.classification
Ciencias Químicas
dc.subject.classification
CIENCIAS NATURALES Y EXACTAS
dc.title
Exploration of the Structure-Activity Relationship of 1,2,4-Oxadiazole Antibiotics
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2016-06-01T13:48:38Z
dc.journal.volume
25
dc.journal.number
21
dc.journal.pagination
4854-4857
dc.journal.pais
Países Bajos
dc.journal.ciudad
Amsterdam
dc.description.fil
Fil: Ding, Derong. University Of Notre Dame-indiana; Estados Unidos
dc.description.fil
Fil: Boudreau, Marc A.. University Of Notre Dame-indiana; Estados Unidos
dc.description.fil
Fil: Leemans, Erika J.. University Of Notre Dame-indiana; Estados Unidos
dc.description.fil
Fil: Spink, Edward. University Of Notre Dame-indiana; Estados Unidos
dc.description.fil
Fil: Yamaguchi, Takao. University Of Notre Dame-indiana; Estados Unidos
dc.description.fil
Fil: Testero, Sebastian Andres. University Of Notre Dame-indiana; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Rosario. Instituto de Química Rosario; Argentina
dc.description.fil
Fil: O'Daniel, Peter I.. University Of Notre Dame-indiana; Estados Unidos
dc.description.fil
Fil: Lastochkin, Elena. University Of Notre Dame-indiana; Estados Unidos
dc.description.fil
Fil: Chang, Mayland. University Of Notre Dame-indiana; Estados Unidos
dc.description.fil
Fil: Mobashery, Shahriar. University Of Notre Dame-indiana; Estados Unidos
dc.journal.title
Bioorganic & Medicinal Chemistry Letters
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S0960894X1500637X
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.bmcl.2015.06.044
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.bmcl.2015.06.044
Archivos asociados